Opening Gates: Global Reproductive Science Research Capacity Building Webinar
This webinar will provide an overview of the landscape of male contraceptive development in 2025, particularly focusing on the following objectives:
-Understanding the need for increased contraceptive options for men and the barriers to male engagement in contraception
-Understanding the biological foundation of novel male hormonal and non-hormonal contraceptives in development
-Predicting the timeline and possible barriers for the introduction of these novel methods to the contraceptive marketplace.
Stephanie Page, MD, PhD (she/her)
Head, Division of Metabolism, Endocrinology and Nutrition
Robert B. McMillen Professor of Lipid Research University of Washington School of Medicine
Dr. Page is Head of the Division of Metabolism, Endocrinology and Nutrition at the University of Washington, where she holds the Robert B. McMillen Professorship in Lipid Research and founding Co-Director of the UW Medicine Diabetes Institute.
Dr. Page runs a large clinical research program focused on male reproduction and the development of effective and reversible male contraceptives. In addition, her group investigates the impact of testosterone on male aging, metabolic health, and disease risk. She has an overall interest in disease prevention, including strategies to minimize unplanned pregnancy and metabolic disease risk across the globe. Dr. Page has a strong commitment to diversifying our healthcare and research communities and has been recognized by the University of Washington as a “Gender Equity Trailblazer” and is a recipient of the “William J. Bremner Mentorship Award”.
Dr. Page earned her bachelor’s degree from Stanford University and her M.D. and Ph.D. in immunology from the University of Washington. She continued her training at UW, including residency in internal medicine and fellowship in endocrinology, before joining the faculty in 2003. Dr. Page is a member of the Endocrine Society and the American Society of Andrology, and was elected to the American Society of Clinical Investigation in 2010. She has published over 120 peer-reviewed articles and has served on the editorial boards of the Journal of Clinical Investigation Insight, Lancet Diabetes and Endocrinology, and the Journal of Clinical Endocrinology and Metabolism.